Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells
First Claim
1. A method for treating a subject having cancer, the method comprising administering a TIM-3 (T cell Immunoglobulin and Mucin domain containing molecule-3) binding molecule in an amount effective to promote T-cell trafficking to a target tissue, wherein the TIM-3 binding molecule is a TIM-3 antibody or antigen-binding fragment thereof, in combination with a chemotherapeutic agent, thereby treating the cancer.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides compositions and methods useful for promoting or reducing T-cell trafficking to a target tissue. Also provided are compositions and methods useful for promoting or inhibiting antigen-presenting cell (APC) activation. The invention is related to discovery of functional characteristics of TIM-3, a molecule that is preferentially expressed on the surface of Th1 cells. The methods are useful for treating disorders including cancer, infectious disease, allergy, asthma, and autoimmune disease.
20 Citations
10 Claims
- 1. A method for treating a subject having cancer, the method comprising administering a TIM-3 (T cell Immunoglobulin and Mucin domain containing molecule-3) binding molecule in an amount effective to promote T-cell trafficking to a target tissue, wherein the TIM-3 binding molecule is a TIM-3 antibody or antigen-binding fragment thereof, in combination with a chemotherapeutic agent, thereby treating the cancer.
Specification